Stay updated on Omalizumab in CRSwNP: Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.
Latest updates to the Omalizumab in CRSwNP: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Locations section now includes Maryland as a study site, and the footer revision updated to v3.3.3; the prior Maryland Locations heading and HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%
- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; this is a minor site update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check52 days agoChange DetectedRemoved the government funding/operating status notice from the page. This change does not affect the study details, eligibility criteria, or other information about the trial.SummaryDifference0.4%
- Check66 days agoChange DetectedPage content remains substantially the same; no new results, eligibility changes, or primary endpoints are introduced, and only minor UI differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check95 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference3%
- Check102 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%
Stay in the know with updates to Omalizumab in CRSwNP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.